NHS Framework for Midlands and East, Branded Medicines - Tranche A and Annual

The NHS Commissioning Board (operating under the name of NHS England)

This public procurement record has 2 releases in its history.

Award

22 Feb 2022 at 09:21

Tender

17 Aug 2021 at 14:20

Summary of the contracting process

The current procurement process is managed by The NHS Commissioning Board (operating under the name of NHS England) for the NHS Framework for Midlands and East, Branded Medicines – Tranche A and Annual Tranche. This open tender is classified under pharmaceutical products and has commenced on 1 March 2022, with the contract running until 29 February 2024, during which extensions may be negotiated at the buyer's discretion. The tender is taking place in the UK, with bids to be submitted electronically via the designated eTendering portal. The official deadline for bids is set for 21 September 2021.

This procurement provides a significant opportunity for businesses involved in the pharmaceutical industry, particularly those offering branded medicines. Suppliers, especially large-scale pharmaceutical companies, may find themselves favoured given the extensive requirements and scale of the framework. Additionally, small and medium-sized enterprises (SMEs) are encouraged to participate as the open nature of the procurement allows for a diverse range of bidders to compete, potentially leading to increased market penetration and business growth within the health sector.

How relevant is this notice?

Notice Title

NHS Framework for Midlands and East, Branded Medicines - Tranche A and Annual

Notice Description

NHS Framework for the Midlands and East, Branded Medicines - Tranche A and Annual Tranche<br/><br/>Offer reference number: CM/PHR/20/5602<br/>CM/PHR/20/5602/01 - NHS Framework for the Midlands and East, Branded Medicines - Tranche A. Period of framework: 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months<br/>CM/PHR/20/5602/02 - NHS Framework for the Midlands and East Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

Lot Information

CM/PHR/20/5602/01 - NHS Framework Mids and East, Branded Medicines-Tranche A

CM/PHR/20/5602/01 - NHS Framework for the Midlands and East, Branded Medicines - Tranche A. Period of framework: 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/20/5602/02 - NHS Framework Mids and East Branded Medicines - Annual

CM/PHR/20/5602/02 - NHS Framework for the Midlands and East Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-02d5e9
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/004917-2022
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£216,078,796 £100M-£1B
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
22 Feb 20224 years ago
Submission Deadline
21 Sep 2021Expired
Future Notice Date
Not specified
Award Date
7 Feb 20224 years ago
Contract Period
1 Mar 2022 - 28 Feb 2023 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
The NHS Commissioning Board (operating under the name of NHS England)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England

Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLF East Midlands (England)

Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
31
Supplier Names

Accord-UK Ltd

Allergan

Almirall

Amgen Ltd

AstraZeneca

Aventis Pharma ltd t/a Sanofi

Bristol Myers Squibb

Celltrion Healthcare United Kingdom Limited

Chugai Pharma UK Ltd

Eli Lilly and Company Ltd

Gedeon Richter UK Ltd

GlaxoSmithKline UK Limited

Ipsen

Janssen-Cilag Ltd

Merck Serono Limited

Merck Sharpe and Dohme (UK) Limited

Merz

Napp Pharmaceuticals Ltd

Novo Nordisk

Organon Pharmaceuticals UK Ltd

Pfizer Ltd

Pharmacosmos UK Ltd

Roche Products Ltd

Sandoz Ltd

Sobi (Swedish Orphan Biovitrum Ltd)

Takeda UK Ltd

Teva UK Limited

Thornton and Ross Ltd

UCB Pharma Ltd

Vifor Pharma UK Ltd

Zentiva Pharma UK Ltd

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...